EPP ETF

WATERTOWN, Mass., Nov. 04, 2024 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases, today announced positive feedback from its end-of-Phase 2 meeting with the U.S. Food and Drug Administration (FDA), supporting the regulatory path forward for bitopertin in EPP.

WATERTOWN, Mass., Nov. 01, 2024 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases, will host a conference call to discuss feedback received from its end-of-Phase 2 (EOP2) meeting with the U.S. Food and Drug Administration (FDA). The conference call will be held on Monday, November 4, at 8:00 am EST.

Disc Medicine, Inc. released positive results from the phase 2 AURORA study, using bitopertin for the treatment of patients with EPP and XLP. Potential FDA feedback to initiate a pivotal study using bitopertin for the treatment of patients with EPP and XLP expected in the 2nd half of 2024. Results from the phase 1/2 study, using DISC-0974 for the treatment of patients with NDD-CKD, expected in the 2nd half of 2024.

Asset managers confirmed that regulators in Hong Kong approved the introduction of spot bitcoin and ether exchange-traded funds (ETFs) on Monday.

Hong Kong has approved its first exchange-traded funds following bitcoin and ether, according to statements from various issuers on Monday. This move has bolstered the overall market and established the city as Asia's first to provide these products, following the U.S. introduction of spot bitcoin ETFs earlier in the year.

According to sources, it is possible that bitcoin exchange-traded funds could be introduced in Hong Kong this month, with the initial approvals expected to be disclosed next week.

(Kitco News) - Hong Kong is assessing whether to allow retail investors to access crypto-related exchange-traded funds amid a push to become the top Asia-Pacific cryptocurrency hub.

HSBC, the banking giant managing nearly $3 trillion in assets, has reportedly allowed its customers to buy Bitcoin and Ethereum exchange-traded funds (ETFs) listed on the Hong Kong stock exchange.